Abstract
Bridging the gap between genetic vãriations, en vironmentãl determinants,ãnd phenot ypic outcomes is critical for supporting clinical diagnosisãnd understanding mechanisms of diseases. It requires integrating open dataãtã global scale. The Monarch Initiativeãdvances these goals b y de v eloping open ontologies, semantic data models,ãnd kno wledge graphs f or translational research. T he Monarch App isãn integrated platform combining dataãbout genes, phenotypes,ãnd diseasesãcross species. Monarch's APIs enableãccess to carefully curated datasetsãndãdvãncedãnaly sis tools that support the understandingãnd diagnosis of disease for diverseãpplications suchãs variant prioritization, deep phenot yping ,ãnd patient profile-matching . We ha v e migrated our sy stem intoã scalable, cloud-based infrastr uct ure; simplified Monarch's data ingestionãnd knowledge graph integration systems; enhanced data mappingãnd integration standards;ãnd de v elopedã ne w user interfãce with no v el searchãnd graph navigation features. Furthermore, weãdvanced Monarch'sãnalytic tools by developingã customized plugin for OpenAI's ChatGPT to increase the reliability of its responsesãbout phenot ypic datã,ãllowing us to interrogate the knowledge in the Monarch graph using state-of-the-art Large Language Models. The resources of the Monarch Initiative can be foundãt monarchinitiative.orgãnd its corresponding code repositoryãt github.com / monarc h-initiative / monarc h-app.
Original language | English |
---|---|
Pages (from-to) | D938-D949 |
Journal | Nucleic Acids Research |
Volume | 52 |
Issue number | D1 |
DOIs | |
State | Published - Jan 5 2024 |
Funding
Office of the Director National Institute of Health [5R24OD011883-12, 3R24OD011883-11S1]; NIH National Human Genome Research Institute [5RM1HG010860-04, 3RM1HG010860-03S1, 5U24HG011449-03]; NIH National Library of Medicine [T15LM009451]; J.R., S.C., S.M., H.H., N.L.H., C.J.M. and J.H.C. were partly supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; Critical Path Institute is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) and FDA/HHS (56.5%), totaling $16749891, and by non-government sources (43.5%), totaling $12895366. Funding for open access charge: NIH [5R24OD011883-12].